Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Electromed Inc. (ELMD:NYSE), powered by AI.
Electromed Inc. is currently trading at $37.55. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Electromed Inc. on Alpha Lenz.
Electromed Inc.'s P/E ratio is 42.1.
“Electromed Inc. trades at a P/E of 42.1 (premium valuation) with strong ROE of 17.2%. 3Y revenue CAGR of 15.4% highlights clear growth momentum.”
Ask for details →Electromed Inc. is a leading manufacturer and distributor of medical devices, primarily focusing on respiratory therapy solutions. The company is renowned for its development of innovative airway clearance products, particularly the SmartVest Airway Clearance System, which assists patients with impaired breathing due to conditions like cystic fibrosis, bronchiectasis, and neuromuscular disorders. Electromed Inc. operates mainly within the healthcare sector, providing advanced solutions that improve patient outcomes and enhance quality of life for individuals with chronic respiratory conditions. The company's commitment to research and development helps it maintain a competitive edge, ensuring its products are at the forefront of medical technology. Electromed Inc.'s significant role in the market is underscored by its focus on expanding accessibility to its medical devices, through strategic partnerships and health care provider networks, thereby reinforcing its presence and influence in the respiratory care segment.
“Electromed Inc. trades at a P/E of 42.1 (premium valuation) with strong ROE of 17.2%. 3Y revenue CAGR of 15.4% highlights clear growth momentum.”
Ask for details →Electromed Inc. (ticker: ELMD) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 177 employees. Market cap is $317M.
The current price is $37.55 with a P/E ratio of 42.12x and P/B of 7.35x.
ROE is 17.18% and operating margin is 15.09%. Annual revenue is $64M.